iVascular recently announced that it received CE mark approval for its BX-covered stent iCover.

Balloon-expanding (BX) covered stents are used to treat arteriosclerotic lesions in renal and iliac arteries and to treat aneurysms and ruptures. The iCover stent adapts to tortuous vessels because of its high flexibility and post-expansion capacity.

iCover is encapsulated with iVascular’s CoverTech technology that attaches the inner and outer ePTFE layers through to ensure complete encapsulation.

The company said it has also started the first clinical evaluations with the iCover stent.

“The first clinical experiences with iCover are remarkable, demonstrating the good features of the stent,” Vicente Riambau, a physician at Hospital Clinic Barcelona, said in a news release. “iCover stands out for its excellent navigability and flexibility, while the radiopaque tantalum markers on its ends provide better visibility under X-rays, which enhances precision during implantation. With the launch of iCover, iVascular offers a complete portfolio to treat all types of peripheral lesions.”